SEC Form 4 · accession 0001127602-17-020202
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Luke A Pomilio
Officer — EVP, Finance & CFO
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 12:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2017 | M | 800 | $0.00 | A | 33,079 | D | |
| Common Stock | Jun 1, 2017 | F | 296 | $51.90 | D | 32,783 | D | |
| Common Stock | Jun 1, 2017 | M | 1,000 | $0.00 | A | 33,783 | D | |
| Common Stock | Jun 1, 2017 | F | 370 | $51.90 | D | 33,413 | D | |
| Common Stock | Jun 1, 2017 | M | 1,000 | $0.00 | A | 34,413 | D | |
| Common Stock | Jun 1, 2017 | F | 370 | $51.90 | D | 34,043 | D | |
| Common Stock | Jun 1, 2017 | M | 650 | $0.00 | A | 34,693 | D | |
| Common Stock | Jun 1, 2017 | F | 241 | $51.90 | D | 34,452 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rsus (restricted Stock Units)F1 | $0.00 | Jun 1, 2017 | M | 800 | D | — | Jun 1, 2022 | Common Stock | 800 | 0 | D |
| Rsus (restricted Stock Units)F1 | $0.00 | Jun 1, 2017 | M | 1,000 | D | — | Jun 1, 2023 | Common Stock | 1,000 | 1,000 | D |
| Rsus (restricted Stock Units)F2 | $0.00 | Jun 1, 2017 | M | 1,000 | D | — | Jul 26, 2023 | Common Stock | 1,000 | 1,000 | D |
| Rsus (restricted Stock Units)F1 | $0.00 | Jun 1, 2017 | M | 650 | D | — | Jun 1, 2024 | Common Stock | 650 | 1,300 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
- F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a five year period with the first 20% of the RSU's vesting June 1, 2014.